Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacnomus 0.03% Cream

Prescription Icon
Prescription Required

Marketer

The Aesthetic Sense

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacnomus 0.03% Cream

Eczema (atopic dermatitis) is treated with Tacnomus 0.03% Cream, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This alleviates itching and improves atopic dermatitis rashes. Apply Tacnomus 0.03% Cream externally, two to four times daily to affected areas, or as directed by your physician. Gently and evenly rub the cream into the skin. Avoid overuse and do not bandage or cover treated skin. Consult your doctor if no improvement is seen after two weeks or if your condition worsens. Common side effects may include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Unless medically necessary, this medication is generally not recommended during pregnancy or breastfeeding.

Primary Ingredients of Tacnomus 0.03% Cream

No text was provided to rewrite.

Uses of Tacnomus 0.03% Cream

Managing atopic dermatitis

Major Benefits of Tacnomus 0.03% Cream:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application details prior to use. Ensure the affected skin is clean and dry before applying the cream. Wash your hands thoroughly afterward, except when the affected area is on your hands.

Common Side effects of Tacnomus 0.03% Cream:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacnomus 0.03% Cream:

Apply this medication solely to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application guidelines. Before application, ensure the affected area is clean and completely dry. Wash your hands thoroughly afterward, except when the affected area is on your hands.

How Tacnomus 0.03% Cream works:

Tacnomus 0.03% Cream, an immunosuppressive agent, reduces skin inflammation (redness and swelling) by inhibiting the action of specific immune cells. This alleviates itching and improves the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tacnomus 0.03% Cream during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Tacnomus 0.03% Cream without significant risk to their infants. Available human data indicates minimal potential harm to the baby.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacnomus 0.03% Cream :

For Tacnomus 0.03% Cream, apply any missed dose promptly. If your next scheduled application is imminent, however, omit the missed dose and resume your usual application routine.

Facts to Know About Tacnomus 0.03% Cream

LabelValue
Chemical Type Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Action Class Calcineurin inhibitor immunosuppressants

FAQs on Tacnomus 0.03% Cream

Tacnomus 0.03% Cream is an immune-modulating medicine that primarily reduces immune system activity. It treats moderate to severe eczema (atopic dermatitis) in adults whose condition is unresponsive to steroids or who experience steroid side effects. By targeting the overactive immune response in atopic dermatitis, which causes inflammation, itching, and dryness, Tacnomus 0.03% Cream alleviates these symptoms.
Applying Tacnomus 0.03% Cream may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These side effects usually subside within a week. Treatment may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacnomus 0.03% Cream offers a safe and effective short-term treatment for atopic dermatitis, exhibiting superior safety compared to other immunosuppressants. Its minimal systemic absorption after topical application results in fewer side effects than oral immunosuppressants.
Tacnomus 0.03% Cream is not a controlled substance because it lacks abuse potential. Controlled substances require authorization from both a doctor and relevant authorities due to their potential for misuse.
Prolonged use of Tacnomus 0.03% Cream may increase the risk of lymphoma (a type of lymph node tumor). Studies show a link between Tacnomus 0.03% Cream (or similar medications) and the development of skin cancer or lymphoma in a small number of patients. If you need to use Tacnomus 0.03% Cream for over six weeks, or if your eczema worsens or fails to improve, consult your doctor.
Tacnomus 0.03% Cream is a non-steroid medication that modifies the immune system. Primarily used for eczema, especially atopic dermatitis, it offers the benefit of avoiding skin thinning and other common steroid side effects.
Tacnomus 0.03% Cream
159
MRP 194
18% off